ORIFARM A/S: Financial statements 2018
CVR: 26058708
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ORIFARM A/S (CVR 26058708) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 1,250,457,000 and a net result of DKK 4,295,000 compared with DKK 4,424,000 the year before. That is an increase of 4.9% compared with the year before. The profit margin was 0.3%. Equity in the 2018 report amounted to DKK 40,593,000. The solvency ratio was 20.9%. The company had 45 employees in the financial year.
- Revenue
- DKK 1,250,457,000
- Gross Profit
- DKK 36,221,000
- Profit/Loss
- DKK 4,295,000
- Equity
- DKK 40,593,000
- Total Assets
- DKK 194,205,000
- Employees
- 45
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 1.3 mia. | 36.2 mio. | 4.3 mio. | 40.6 mio. | 45 |
| 2017 | 1.2 mia. | 34.5 mio. | 4.4 mio. | 36.3 mio. | 42 |
| 2016 | 1.2 mia. | 58 mio. | 3.6 mio. | 31.9 mio. | 72 |
| 2015 | 1 mia. | 52.2 mio. | 5.4 mio. | 28.2 mio. | - |
| 2014 | 1.1 mia. | 46.8 mio. | 4.4 mio. | 22.8 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
ORIFARM A/S has published its annual report for 2017. Revenue came to DKK 1,192,494,000, and the net result was DKK 4,424,000.
About ORIFARM A/S
ORIFARM A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JUT NR. 2181 A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM PI A/S. The company has 39 employees (2026). In 2025, the company reported revenue of DKK 1,174,659,000 and a net result of DKK 9,727,000 compared with DKK 14,865,000 the year before. Equity in the 2025 report amounted to DKK 44,048,000.